Ginkgo Bioworks DNA Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$76.06M+16.4% | -$80.75M+24.9% | -$80.76M-43.2% | -$60.3M+72.2% | -$90.96M+45.2% | ||
| $12.8M-13.6% | $13.66M-12.7% | $14.17M-17.5% | $16.34M-5.7% | $14.82M+15.2% | ||
| $15.85M-8.8% | $21.03M+2.3% | $17.84M+28.8% | $25.29M-31.9% | $17.39M-57.4% | ||
| -$46.69M+9.4% | -$47.68M-12.4% | -$31.61M+69.5% | -$40.25M+52.3% | -$51.52M+42.3% | ||
| $1.93M-74.6% | $5K-100.0% | $0-100% | $38K-99.9% | $7.62M+13.6% | ||
| $23.13M+112% | —— | -$72.82M-614% | -$63.89M-138% | -$198.68M-1,541% | ||
| -$19K+90.8% | $8.14M+4,111% | $9.94M+2,237% | -$98K+56.6% | -$207K+75.5% | ||
| -$23.7M+90.5% | —— | -$94.39M+17.3% | -$104.05M+6.7% | -$250.34M-145% | ||
| -$48.62M+17.8% | -$47.68M+15.1% | -$31.61M+73.3% | -$40.29M+63.8% | -$59.14M+38.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Ginkgo Bioworks generate?
- Ginkgo Bioworks (DNA) generated -$166.2M in operating cash flow over the trailing twelve months.
- What is Ginkgo Bioworks's free cash flow?
- After $2.0M of capital expenditures, Ginkgo Bioworks's free cash flow was -$168.2M over the trailing twelve months, up 51.3% year over year.
- Where does Ginkgo Bioworks's cash flow data come from?
- Every line is extracted from Ginkgo Bioworks's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
